Immunogenicity of 3+1 Versus 2+1 Schedule for PCV7

NCT02040402 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Infectious Disease

Interventions

BIOLOGICAL: 7-valent pneumococcal conjugated vaccine
BIOLOGICAL: 7-valent pneumococcal conjugated vaccine

Sponsor

The University of Hong Kong

Collaborators

[object Object]